Press Releases from DelveInsight Business Research LLP (5113 total)
Skin Neoplasms Treatment Market Size Report 2032: Emerging Therapies and Future …
DelveInsight's "Skin Neoplasms Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Skin Neoplasms, historical and forecasted epidemiology as…
Cutaneous Squamous cell Carcinom Treatment Market Size Report 2034: Emerging The …
DelveInsight's "Cutaneous Squamous Cell Carcinoma Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cutaneous Squamous Cell Carcinoma (CSCC), historical…
Basal Cell Carcinoma (Basal Cell Epithelioma) Treatment Market Size Report 2034: …
DelveInsight's "Basal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of Basal Cell Carcinoma, historical and forecasted epidemiology as well…
Cutaneous Lupus Erythematosus Treatment Market Size Report 2034: Emerging Therap …
DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cutaneous Lupus Erythematosus, historical and forecasted epidemiology…
Warts Treatment Market Size Report 2032: Emerging Therapies and Future Growth Op …
DelveInsight's "Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Warts, historical and forecasted epidemiology as well as the Warts…
Sjogren's Syndrome Pipeline Appears Robust With 15+ Key Pharma Companies Activel …
DelveInsight's, "Sjogren's syndrome Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Sjogren's syndrome pipeline landscape. It covers the…
MELAS Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively Wor …
DelveInsight's "MELAS Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in MELAS Syndrome pipeline landscape. It covers the…
Autism Spectrum Disorder Pipeline Appears Robust With 18+ Key Pharma Companies A …
DelveInsight's, "Autism Spectrum Disorder Pipeline Insight, 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Autism Spectrum Disorder pipeline landscape. It…
Familial Adenomatous Polyposis Pipeline Appears Robust With 4+ Key Pharma Compan …
"DelveInsight's, "Familial adenomatous polyposis Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Familial adenomatous polyposis pipeline landscape. It…
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the…
Acute Graft-versus-Host Disease Pipeline 2025: Groundbreaking Clinical Advanceme …
With Acute Graft-versus-Host Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline 2025: Groundbreaking …
With Chemotherapy Induced Peripheral Neuropathy (CIPN) reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
Chronic Myelomonocytic Leukemia Pipeline 2025: Groundbreaking Clinical Advanceme …
With Chronic Myelomonocytic Leukemia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is…
Diabetic Macular Edema Pipeline 2025: Groundbreaking Clinical Advancements by 45 …
With Diabetic Macular Edema reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is…
Mantle Cell Lymphoma Pipeline 2025: Groundbreaking Clinical Advancements by 20+ …
With Mantle Cell Lymphoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Acute Myeloid Leukemia Pipeline 2025: Groundbreaking Clinical Advancements by 11 …
With Acute Myeloid Leukemia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
ATTR Amyloidosis Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Globa …
With ATTR Amyloidosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Cytomegalovirus (CMV) Infection Pipeline 2025: Groundbreaking Clinical Advanceme …
With Cytomegalovirus (CMV) Infection reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Hepatic-colorectal Metastasis Pipeline 2025: Groundbreaking Clinical Advancement …
With Hepatic-colorectal Metastasis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Neurofibromatosis Type 1 Drugs Market Size Report 2034: Emerging Therapies and F …
DelveInsight's "Neurofibromatosis Type 1 Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Neurofibromatosis Type 1, historical and forecasted epidemiology as…
Sly Syndrome Treatment Market Size Report 2032: Emerging Therapies and Future Gr …
DelveInsight's "Sly Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sly Syndrome, historical and forecasted epidemiology as well as…
Congenital Diarrheal Disorders Treatment Market Size Report 2032: Emerging Thera …
DelveInsight's "Congenital Diarrheal Disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Congenital Diarrheal Disorders, historical and forecasted epidemiology as…
X Linked Hypophosphatemia Treatment Market Size Report 2032: Emerging Therapies …
DelveInsight's "X Linked Hypophosphatemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X Linked Hypophosphatemia, historical and forecasted epidemiology as…
Ehlers-Danlos Syndrome Market Outlook 2032: Emerging Therapies and Future Growth …
DelveInsight's "Ehlers-Danlos Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ehlers-Danlos Syndrome, historical and forecasted epidemiology as well as…
22q11.2 Deletion Syndrome Market Size Report 2034: Emerging Therapies and Future …
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as…
Myotubular Myopathy Market Outlook 2032: Emerging Therapies and Future Growth Op …
DelveInsight's "Myotubular Myopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myotubular Myopathy, historical and forecasted epidemiology as well as…
Germ Cell Tumors Market: Epidemiology, Therapies, Companies, DelveInsight | Take …
Germ Cell Tumors emerging therapies such as Cabozantinib, are expected to boost the Germ Cell Tumors Market in the upcoming years.
DelveInsight has launched a new…
Giant Cell Arteritis Pipeline 2025: Groundbreaking Clinical Advancements by 80+ …
With Giant Cell Arteritis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Pheochromocytoma Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Globa …
With Pheochromocytoma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Presbyopia Pipeline 2025: Groundbreaking Clinical Advancements by 10+ Global Lea …
With Presbyopia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Primary Ciliary Dyskinesia Pipeline 2025: Groundbreaking Clinical Advancements b …
With Primary Ciliary Dyskinesia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
ALK+ NSCLC Pipeline Appears Robust With 6+ Key Pharma Companies Actively Working …
DelveInsight's, "ALK+ NSCLC Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK+ NSCLC pipeline landscape. It covers the…
Prosthetic Heart Valves Market Analysis, Trends & Future Outlook 2032 | DelveIns …
DelveInsight's Prosthetic Heart Valves Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies market shares, challenges, Market Drivers, barriers, trends,…
Medical Device Cleaning Market Analysis, Trends & Future Outlook 2032 | DelveIns …
DelveInsight's Medical Device Cleaning Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies market shares, challenges, Market Drivers, barriers, trends,…
Protein Expression Market Analysis, Trends & Future Outlook 2032 | DelveInsight
DelveInsight's Protein Expression Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies market shares, challenges, Market Drivers, barriers, trends, and…
Real-World Evidence Solution Market Analysis, Trends & Future Outlook 2032 | Del …
DelveInsight's Real-World Evidence Solution Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies market shares, challenges, Market Drivers, barriers, trends,…
Cushing's disease Pipeline 2025: Groundbreaking Clinical Advancements by 4+ Glob …
With Cushing's disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology,…
Hyperparathyroidism Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Gl …
With Hyperparathyroidism reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
HER2 Low Cancers Market: Epidemiology, Therapies, Companies, DelveInsight | Daii …
HER2 Low Cancers therapies, such as ENHERTU, DATROWAY (datopotamab deruxtecan), AIDIXI (disitamab vedotin), TRODELVY (sacituzumab govitecan), DB-1303, BNT323 (trastuzumab pamirtecan), Eftilagimod alpha (IMP321), Ifinatamab deruxtecan,…
WHIM Syndrome Pipeline 2025: Groundbreaking Clinical Advancements by 80+ Global …
With WHIM Syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Lipodystrophy Pipeline 2025: Groundbreaking Clinical Advancements by 8+ Global L …
With Lipodystrophy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Minimal residual disease Pipeline 2025: Groundbreaking Clinical Advancements by …
With Minimal residual disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Alcohol Use Disorder Pipeline 2025: Groundbreaking Clinical Advancements by 30+ …
With Alcohol Use Disorder reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Von Willebrand's Disease Pipeline 2025: Groundbreaking Clinical Advancements by …
With Von Willebrand's Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Celiac Disease Pipeline 2025: Groundbreaking Clinical Advancements by 80+ Global …
With Celiac Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Cutaneous Lupus Erythematosus Treatment Market Size to Expand Significantly by 2 …
DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cutaneous Lupus Erythematosus, historical and forecasted epidemiology…
Warts Treatment Market Size Set for Robust Growth by 2032, estimates DelveInsigh …
DelveInsight's "Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Warts, historical and forecasted epidemiology as well as the Warts…
mRNA Synthesis and Manufacturing Market Report 2032: Strategic Insights, Develop …
DelveInsight's mRNA Synthesis and Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies market shares, challenges, mRNA Synthesis and…
Pulsed Lavage Systems Devices Market Report 2032: Strategic Insights, Developmen …
DelveInsight's Pulsed Lavage Systems Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Companies market shares, challenges, Market Drivers, barriers,…
